Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping the largest market in the region, including the fast regulatory approval process in place. With value-based healthcare an increasingly hot topic, she explains how Biologix has moved to sign the first risk-sharing agreement with Saudi Arabia for a spinal muscular atrophy product; the first in the MENA region.
STAY UP TO DATE NEWS & EVENTS
Related EVENTS & NEWS
Biologix at the 5th Middle East Pharmacoeconomics and Drug Policy Summit
Ana Fareed's Inspiring Visit to Biologix
17th Annual Saudi Pulmonary Hypertension Conference
Biologix participated in the 17th Annual Conference of the Saudi Association for Pulmonary Hypertension, that took place at the Marriott Riyadh in Saudi Arabia from February 15th to 17th, 2024.
